Lantus Sanofi

Links shared publicly online about this topic

Sanofi rebuffs renewed Lantus cancer worries | Reuters

reuters.com — “LONDON (Reuters) - A Swedish study has rekindled concerns about a possible link between Sanofi's top-selling insulin drug Lantus and cancer, but the French drugmaker said on Wednesday the observationalView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on December 7, 2011 at 11:37 am By:

Health_News_OW Health News OW OW Health

Sanofi rebuffs renewed Lantus cancer worries: LONDON (Reuters) - A Swedish study has rekindled concerns about a ... http://t.co/QMPYBKTe

6 months ago...

Sanofi's Lantus avoids meltdown after cancer scare | Reuters

reuters.com — “* Prescriptions for diabetes treatment holding up * Analysts review worst-case forecasts for Lantus sales * Sanofi expected to reiterate confidence at H1 results * Shares up 2.6 percent ByView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on July 28, 2009 at 2:19 pm By:

reutersBenHir Ben Hirschler Health Communicator

Sanofi's Lantus avoids sales meltdown for now at least. But expect story to come back at EASD meeting in Sept http://tinyurl.com/m8xj9b

3 years ago...

Sanofi-Aventis To Personalise Blockbuster Drug Lantus

store.businessmonitor.com — “It is the BMI Pharmaceuticals and Healthcare team's view that personalised medicines - defined as the use of information about a person's genes to prevent, diagnose and treat a disease - will play a gView full resource at store.businessmonitor.com

  • View Related
  • Share

Most Recently Shared on April 2, 2010 at 2:33 am By:

CureT1Diabetes Ellen H Ullman Social Worker

sanofi aventis to personalize blockbuster drug lantus http://bit.ly/aDOc7j (AgaMatrix meters with sanofi-aventis insulins) diabetes

2 years ago...

UPDATE 1-Sanofi dismissive of poor quality Lantus studies | Reuters

reuters.com — “* CEO warns against risk from junk science * Sanofi to work with others to probe Lantus risks further * Prospective randomised study not practical, takes too long (Adds details, background)View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on June 30, 2009 at 6:56 am By:

reutersBenHir Ben Hirschler Health Communicator

Sanofi CEO comes out fighting on Lantus, with swipes at "poor quality studies" and "junk science" http://tinyurl.com/kpt4ma

3 years ago...

Sanofi may suffer, whatever final Lantus verdict | Reuters

reuters.com — “LONDON (Reuters) - The history of past drug scares suggests concerns over the safety of Sanofi-Aventis's diabetes treatment Lantus will hit sales, whether or not a suggested link to cancerView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on June 26, 2009 at 1:15 pm By:

ivanoransky Ivan Oransky Doctor and Health Communicator

Avandia all over again? Wall Street analysts suggesting Sanofi-Aventis' diabetes treatment Lantus may be linked to cancer http://is.gd/1ejIV

3 years ago...

Sanofi's Lantus avoids meltdown after cancer scare | Reuters

reuters.com — “* Prescriptions for diabetes treatment holding up * Analysts review worst-case forecasts for Lantus sales * Sanofi expected to reiterate confidence at H1 results * Shares up 2.6 percent ByView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on July 28, 2009 at 2:26 pm By:

ivanoransky Ivan Oransky Doctor and Health Communicator

Sales of Lantus, long-acting insulin, hold up, despite studies possibly linking it to cancer RT @reutersBenHir http://is.gd/1R8Yc

3 years ago...

Sanofi launches Lantus safety studies - FiercePharma

fiercepharma.com — “Remember the quick furor over the safety of Sanofi-Aventis' insulin drug Lantus? As you'll recall, the company quickly fought back against a couple of studies that appeared to link Lantus to an... Read more...View full resource at fiercepharma.com

  • View Related
  • Share

Most Recently Shared on September 29, 2009 at 10:36 pm By:

rntolaw Claire Nurse

Sanofi launches Lantus safety studieshttp://twurl.nl/4dtnck

3 years ago...

FDA plays down cancer link with Sanofi's Lantus | Reuters

feeds.reuters.com — “NEW YORK/WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Wednesday cast doubt on recent studies that suggested possible cancer risk with Sanofi-Aventis' widely used Lantus diabetes drug,View full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on July 1, 2009 at 8:51 pm By:

Sanofi launches Lantus safety studies - Pharma Marketing Network Forums

forums.pharma-mkting.com — “Sanofi launches lantus safety studies news direct from drug industryView full resource at forums.pharma-mkting.com

  • View Related
  • Share

Most Recently Shared on September 29, 2009 at 8:10 pm By:

pharmaguy John Mack Health Executive

Sanofi-aventis launches major insulin research program to test safety of Lantus. http://bit.ly/fI3X0

3 years ago...

Sanofi may suffer, whatever final Lantus verdict | Reuters

uk.reuters.com — “* Fear that damaging safety analysis will be published soon * Potential parallel seen to scare over Glaxo's Avandia * Lantus is key driver for Sanofi as other drugs decline * Sanofi shares fall 7View full resource at uk.reuters.com

  • View Related
  • Share

Most Recently Shared on June 26, 2009 at 11:42 am By:

reutersBenHir Ben Hirschler Health Communicator

Sales of Sanofi's #Lantus will be hit, whatever the final verdict - Avandia deja vu? http://uk.reuters.com/article/idUKLQ15768320090626

3 years ago...

Amid Lantus furor, Sanofi restructures - FiercePharma

fiercepharma.com — “Sanofi-Aventis tops the news again today, this time with more details of its restructuring plan. The French drugmaker will shutter four facilities in its home country and sell a fifth, with plans to... Read more...View full resource at fiercepharma.com

  • View Related
  • Share

Most Recently Shared on June 30, 2009 at 7:55 pm By:

ONClive Editor Oncology

RT @FiercePharma Sanofi to close 4 units in France, sell 5th; closures in Japan, US, UK, Spain. "Voluntary departures." http://is.gd/1jdJP

3 years ago...

Sanofi Shares Fall on Concern Over Lantus Cancer Risk (Update3) - BusinessWeek

businessweek.com — “Sanofi-Aventis SA fell the most in a month in Paris trading on renewed concern that the Lantus diabetes treatment, the French drugmaker's top-selling product, may be linked to an increased risk of cancer.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on June 18, 2010 at 12:13 pm By:

Ad-ucation? Sorvinos plug Lantus in Sanofi web effort - Medical Marketing and Media

mmm-online.com — “Sanofi Aventis launched a Lantus-branded diabetes awareness campaign featuring Paul and Mira Sorvino.View full resource at mmm-online.com

  • View Related
  • Share

Most Recently Shared on September 21, 2010 at 8:11 pm By:

Life4D Euro RSCG Life 4D Health Marketing

Big day for our Sanofi US Diabetes clients. First, Facebook. Now Diabetes CoStars: http://bit.ly/cWKTjK

2 years ago...

Diabetics urged to stay on popular insulin Lantus | Reuters

feeds.reuters.com — “CHICAGO (Reuters) - Dr. Louis Philipson has already started fielding calls from worried diabetics after new studies of 300,000 patients released on Friday suggested the Sanofi-Aventis insulin drug LantusView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on June 29, 2009 at 10:09 pm By:

Reuters_Health Reuters Health Health News

Diabetics urged to stay on popular insulin Lantus http://r.reuters.com/wuv87c

3 years ago...

Study: Sanofi’s Lantus Insulin Has Possible Cancer Link - Health Blog - WSJ

blogs.wsj.com — “The French drug giant, whose stock fell more than 7%, said "no definitive conclusions can be drawn" from the data.View full resource at blogs.wsj.com

  • View Related
  • Share

Most Recently Shared on June 26, 2009 at 11:38 pm By:

WSJHealthBlog WSJ Health Blog Health News

Study: Sanofi’s Lantus Insulin Has Possible Cancer Link http://bit.ly/vsR9k

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • Health_News_OW

    Health News OW

    Organizing health news and resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

  • reutersBenHir

    Ben Hirschler

    Pharma, biotech, health and science correspondent at Reuters in London. Any opinions expressed are my own.

    View Profile

  • CureT1Diabetes

    Ellen H Ullman

    MSW, Activities Director @DayscapeFL, Dedicated to a cure for type 1 diabetes,VP @cwdfoundation,PEP Squad @diabetes_dri, quintessentially resourceful

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390